Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Paula Kareclas · SciRah

Researcher profile · Semantic Scholar

Paula Kareclas

Share profile

Paula Kareclas — researcher profile on SciRah

h-index: 8
Works: 10
Citations: 772

Most-cited papers

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial.
H. Ford, A. Marshall, J. Bridgewater, T. Janowitz +14 more
2014The Lancet Oncology563 citations Open access
Semantic Scholar
Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy.
A. Hill, S. Ridley, D. Esser, R. G. Oldroyd +8 more
2006Blood60 citations Open access
Semantic Scholar
Rationale and study design of the Adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D): a non-randomised, open label, adaptive dose finding trial
F. Waldron-Lynch, Paula Kareclas, K. Irons, N. Walker +4 more
2014BMJ Open44 citations Open access
Semantic Scholar
COUGAR-02: A randomized phase III study of docetaxel versus active symptom control in advanced esophagogastric adenocarcinoma.
H. Ford, A. Marshall, J. Wadsley, F. Coxon +12 more
201331 citations
Semantic Scholar
A phase 2 study of vatalanib in metastatic melanoma patients.
N. Cook, B. Basu, S. Biswas, Paula Kareclas +10 more
2010European Journal of Cancer23 citations Open access
Semantic Scholar
Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive study
Lucy A. Truman, M. Pekalski, Paula Kareclas, Marina Evangelou +8 more
2015BMJ Open19 citations Open access
Semantic Scholar
Cougar-02 : a randomized phase III study of docetaxel versus active symptom control in patients with relapsed esophago-gastric adenocarcinoma
N. Cook, A. Marshall, J. Blazeby, J. Bridgewater +13 more
201315 citations
Semantic Scholar
Targeting patient recovery priorities in degenerative cervical myelopathy: design and rationale for the RECEDE-Myelopathy trial—study protocol
B. Davies, O. Mowforth, S. Yordanov, Daniel Alvarez-Berdugo +21 more
2023BMJ Open12 citations Open access
Semantic Scholar
A phase II study of PTK787 in metastatic melanoma patients.
P. Corrie, Paula Kareclas, C. Mann, C. Palmer +5 more
20083 citations
Semantic Scholar
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma ( COUGAR-02 ) : an open-label , phase 3 randomised controlled trial
H. Ford, A. Marshall, J. Bridgewater, T. Janowitz +14 more
20131 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. Ford×4
Invite
H. Ford — researcher profile on SciRah
A. Marshall×4
Invite
A. Marshall — researcher profile on SciRah
J. Bridgewater×4
Invite
J. Bridgewater — researcher profile on SciRah
F. Coxon×4
Invite
F. Coxon — researcher profile on SciRah

×4

Invite

J. Wadsley — researcher profile on SciRah

Invite

W. Mansoor — researcher profile on SciRah

S. Madhusudan×4

Invite

S. Madhusudan — researcher profile on SciRah

G. Middleton×4

Invite

G. Middleton — researcher profile on SciRah

Invite

D. Swinson — researcher profile on SciRah

Invite

S. Falk — researcher profile on SciRah

Invite

I. Chau — researcher profile on SciRah

Invite

N. Cook — researcher profile on SciRah